384
Views
31
CrossRef citations to date
0
Altmetric
Original

Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people

, PhD , MD, , , , , , , , & show all
Pages 183-192 | Received 19 Oct 2008, Published online: 07 Jul 2009

References

  • Halliwell B, Gutteridge JMC. Oxidative stress. Free radicals in biology and medicine3rd ed, B Halliwell, JMC Gutteridge. Oxford University Press, New York 1999; 246–350
  • Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002; 511: 73–86
  • Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?. FEBS Lett 1997; 411: 157–160
  • Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708–1714
  • Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393–397
  • Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383–9387
  • Davì G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224–229
  • Gopaul NK, Anggård EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995; 368: 225–229
  • Nanji AA, Khwaja S, Tahan SR, Sadrzadeh SM. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcohol liver disease. J Pharmacol Exp Ther 1994; 269: 1280–1285
  • Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 2000; 33(Suppl)S85–S97
  • Cooke MS, Evans MD, Herbert KE, Lunec J. Urinary 8-oxo-2′-deoxyguanosine–source, significance and supplements. Free Radic Res 2000; 32: 381–397
  • Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91: 327–329
  • Akagi S, Nagake Y, Kasahara J, Sarai A, Kihara T, Morimoto H, Yano A, Nakao K, Nanba K, Ichikawa H, Makino H. Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with chronic renal failure. Nephrology (Carlton) 2003; 8: 192–195
  • Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 2003; 334: 87–94
  • Wong RH, Yeh CY, Hsueh YM, Wang JD, Lei YC, Cheng TJ. Association of hepatitis virus infection, alcohol consumption and plasma vitamin A levels with urinary 8-hydroxydeoxyguanosine in chemical workers. Mutat Res 2003; 535: 181–186
  • Kim JY, Mukherjee S, Ngo LC, Christiani DC. Urinary 8-hydroxy-2′-deoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to fine particulates. Environ Health Perspect 2004; 112: 666–671
  • Kuo HW, Chang SF, Wu KY, Wu FY. Chromium (VI) induced oxidative damage to DNA: increase of urinary 8-hydroxydeoxyguanosine concentrations (8-OHdG) among electroplating workers. Occup Environ Med 2003; 60: 590–594
  • Kimura S, Yamauchi H, Hibino Y, Iwamoto M, Sera K, Ogino K. Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. Basic Clin Pharmacol Toxicol 2006; 98: 496–502
  • Matsuzawa, Y, Inoue, S, Ikeda, Y, Sakata, T, Saito, Y, Sato, Y, Shirai, K, Oono, M, Miyazaki, S, Tokunaga, K, Fukagawa, K, Nakamura, T. A new criteria of obesity. J Jpn Soc Study Obesity 2000;6:18–28 ( in Japanese).
  • Matsuzawa, Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Jpn Soc Int Med 2005;94:188–203 ( in Japanese).
  • Hiro, H, Shima, S. Availability of the Alcohol Use Disorders Identification Test (AUDIT) for a complete health examination in Japan. Nihon Arukoru Yakubutsu Igakkai Zasshi 1996;31:437–450 ( in Japanese).
  • Takahashi, K, Yoshimura, Y, Kaimoto, T, Kunii, D, Komatsu, T, Yamamoto, S. Validation of a food frequency questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 2001;59:221–232 ( in Japanese).
  • Helmersson J, Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 203–235
  • Møller P, Loft S. Dietary antioxidants and beneficial effect on oxidatively damaged DNA. Free Radic Biol Med 2006; 41: 388–415
  • Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K. Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 2000; 107: 39–44
  • Jackson MJ, Pye D, Palomero J. The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 2007; 102: 1664–1670
  • Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708–1714
  • Sachdev S, Davies KJ. Production, detection, and adaptive responses to free radicals in exercise. Free Radic Biol Med 2008; 44: 215–223
  • Mastaloudis A, Leonard SW, Traber MG. Oxidative stress in athletes during extreme endurance exercise. Free Radic Biol Med 2001; 31: 911–922
  • Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003; 189: 41–54
  • Jackson MJ. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function?. Free Radic Biol Med 2008; 44: 132–141
  • Lee DH, Blomhoff R, Jacobs DR, Jr. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 2004; 38: 535–539
  • Halliwell B, Gutteridge JMC. Reactive species can be poisonous. Free radicals in biology and medicine4th ed, B Halliwell, JMC Gutteridge. Oxford University Press, New York 2007; 440–487
  • Aleynik SI, Leo MA, Aleynik MK, Lieber CS. Increased circulating products of lipid peroxidation in patients with alcohol liver disease. Alcohol Clin Exp Res 1998; 22: 192–196
  • Adachi J, Matsushita S, Yoshioka N, Funae R, Fujita T, Higuchi S, Ueno Y. Plasma phosphatidylcholine hydroperoxide as a new marker of oxidative stress in alcohol patients. J Lipid Res 2004; 45: 967–971
  • Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505–513
  • Yoshida R, Shioji I, Kishida A, Ogawa Y. Moderate alcohol consumption reduces urinary 8-hydroxydeoxyguanosine by inducing of uric acid. Ind Health 2001; 39: 322–329
  • Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19–25
  • Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992; 13: 2241–2247
  • van Zeeland AA, de Groot AJ, Hall J, Donato F. 8-Hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat Res 1999; 439: 249–257
  • Smith CJ, Fischer TH, Heavner DL, Rumple MA, Bowman DL, Brown BG, Morton MJ, Doolittle DJ. Urinary thromboxane, prostacyclin, cortisol, and 8-hydroxy-2'-deoxyguanosine in nonsmokers exposed and not exposed to environmental tobacco smoke. Toxicol Sci 2001; 59: 316–323
  • Mizoue T, Tokunaga S, Kasai H, Kawai K, Sato M, Kubo T. Body mass index and oxidative DNA damage: a longitudinal study. Cancer Sci 2007; 98: 1254–1258
  • Ichiba M, Yamada S, Ishii K, Gonda K, Murai R, Shimomura T, Saeki T, Kanbe T, Tanabe Y, Yoshida Y, Tsuchiya H, Hoshikawa Y, Kurimasa A, Kishimoto Y, Kawasaki H, Shiota G. Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients. Hepatogastroenterology 2007; 54: 1736–1740
  • Hofer T, Karlsson HL, Möller L. DNA oxidative damage and strand breaks in young healthy individuals: a gender difference and the role of life style factors. Free Radic Res 2006; 40: 707–714
  • Pilger A, Germadnik D, Riedel K, Meger-Kossien I, Scherer G, Rüdiger HW. Longitudinal study of urinary 8-hydroxy-2'-deoxyguanosine excretion in healthy adults. Free Radic Res 2001; 35: 273–280
  • Dong QY, Cui Y, Chen L, Song J, Sun L. Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients. Eur J Ophthalmol 2008; 18: 94–98
  • Frost MT, Halliwell B, Moore KP. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J 2000; 345: 453–458
  • Ryberg H, Caidahl K. Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 851: 160–171
  • Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005; 25: 279–286
  • Michoulas A, Tong V, Teng XW, Chang TK, Abbott FS, Farrell K. Oxidative stress in children receiving valproic acid. J Pediatr 2006; 149: 692–696
  • Shibata H, Nabika T, Moriyama H, Masuda J, Kobayashi S. Correlation of NO metabolites and 8-iso-prostaglandin F2a with periventricular hyperintensity severity. Arterioscler Thromb Vasc Biol 2004; 24: 1659–1663
  • Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tarnopolsky MA. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 2008; 45: 503–511
  • Davì G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008–2014
  • Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin LJ, Puddey IB. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic Biol Med 2007; 42: 1730–1735
  • Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med 2003; 34: 409–418
  • Frenkel K, Zhong ZJ, Wei HC, Karkoszka J, Patel U, Rashid K, Georgescu M, Solomon JJ. Quantitative high-performance liquid chromatography analysis of DNA oxidized in vitro and in vivo. Anal Biochem 1991; 196: 126–136
  • Lin HS, Jenner AM, Ong CN, Huang SH, Whiteman M, Halliwell B. A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2′-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem J 2004; 380: 541–548
  • Yin B, Whyatt RM, Perera FP, Randall MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med 1995; 18: 1023–1032
  • Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol Biomarkers Prev 2002; 11: 767–770

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.